Literature DB >> 624188

Arginase deficiency in multiple tissues in argininemia.

V V Michels, A L Beaudet.   

Abstract

A 5 9/12-year-old Mexican female with argininemia presented at 4 years of age with severe growth retardation, microcephaly, mental retardation, loss of ability to walk, spasticity and epileptiform electroencephalogram. At follow-up, blood ammonia was elevated only twice out of 30 determinations. Blood arginine was 544 to 1,074 mumol/l (normal 61 to 173); cerebrospinal fluid arginine was 88 mumol/l (normal 6 to 29); and urinary arginine, citruline and argininosuccinic acid were consistently elevated. Arginase activities in tissues from the propositus were 0.01 mU/mg hemoglobin in erythrocytes (normal 29.8 to 96.1); 9 mU/mg protein in liver (normal 1,522 to 5,491); and 5 mU/mg protein in stratum corneum (normal 2,856 to 7,556). The demonstration of arginase deficiency in liver and stratum corneum suggests a generalized deficiency and helps to explain the elevation of blood arginine. Therapeutic trials of orally administered lysine to enhance dibasic amino acid competition and of enzyme replacement using erythrocyte transfusion did not result in significantly decreased blood arginine or clinical improvement.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 624188     DOI: 10.1111/j.1399-0004.1978.tb04128.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  15 in total

1.  Molecular genetic study of human arginase deficiency.

Authors:  W W Grody; D Klein; A E Dodson; R M Kern; P B Wissmann; B K Goodman; P Bassand; B Marescau; S S Kang; J V Leonard
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

2.  Differential expression of the two human arginase genes in hyperargininemia. Enzymatic, pathologic, and molecular analysis.

Authors:  W W Grody; C Argyle; R M Kern; G J Dizikes; E B Spector; A D Strickland; D Klein; S D Cederbaum
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

Review 3.  Arginase-1 deficiency.

Authors:  Yuan Yan Sin; Garrett Baron; Andreas Schulze; Colin D Funk
Journal:  J Mol Med (Berl)       Date:  2015-10-14       Impact factor: 4.599

4.  Arginase I mRNA therapy - a novel approach to rescue arginase 1 enzyme deficiency.

Authors:  Kirtika H Asrani; Lei Cheng; Christopher J Cheng; Romesh R Subramanian
Journal:  RNA Biol       Date:  2018-07-24       Impact factor: 4.652

5.  A new French-Canadian family affected by hyperargininaemia.

Authors:  I A Qureshi; J Letarte; R Ouellet; J Larochelle; B Lemieux
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

6.  Treatment of hyperargininaemia due to arginase deficiency with a chemically defined diet.

Authors:  S D Cederbaum; S J Moedjono; K N Shaw; M Carter; E Naylor; M Walzer
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

7.  Absence of erythrocyte arginase protein in Japanese patients with hyperargininemia.

Authors:  C Hayakawa; S Aono; H Keino; N Mizutani; K Watanabe; M Ikemoto; M Totani; T Murachi; S Kashiwamata
Journal:  Eur J Pediatr       Date:  1991-09       Impact factor: 3.183

8.  Regulation of expression of genes for enzymes of the mammalian urea cycle in permanent cell-culture lines of hepatic and non-hepatic origin.

Authors:  D F Haggerty; E B Spector; M Lynch; R Kern; L B Frank; S D Cederbaum
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

9.  Arginase deficiency manifesting delayed clinical sequelae and induction of a kidney arginase isozyme.

Authors:  W W Grody; R M Kern; D Klein; A E Dodson; P B Wissman; S H Barsky; S D Cederbaum
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

10.  Urinary pyrimidine excretion in arginase deficiency.

Authors:  E W Naylor; S D Cederbaum
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.